Jalpa A. Doshi PhD, Assistant Professor of Medicine, General Internal Medicine, Director, Economic Evaluations Unit, Center for Evidence-Based Practice, Director, Value-Based Insurance Design Initiatives, Center for Health Incentives, University of Pennsylvania, Philadelphia, PA, USA
Bonnie Handke RN, Director, Health Policy and Planning, Medtronic, Inc, Neuromodulation, Shoreview, MN, USA
Jennifer Stephens PharmD, Clinical Director& Partner, Pharmerit North America LLC, Bethesda, MD, USA

Gisselle Gallego PhD, Research Fellow, Centre for Health Economics Research and Evaluation (CHERE) University of Sydney, Australia
Wim Goettsch PhD, Consultant Pharmacoeconomics Dutch Health Insurance Board, Diemen, Netherland
Seema Haider MSc, Director, Pfizer Inc, Global HE/OR,Groton, CT, USA
Franz Hessel MD, MPH, Senior Manager, Sanofi-Aventis, Managed Markets / HEOR, Berlin, Germany
Tove Holm-Larsen MSc, University of Denmark, Denmark
Deborah Lubeck PhD, Vice President Icon Clinical Research, Half Moon Bay, CA, USA
John O'Donnell PhD, Regional Director, Astra-Zeneca, New York, NY, USA
Dan Ollendorf MPH, Chief Review Officer, Institute for Clinical and Economic Review, Boston, MA, USA
Carlos Gouveia Pinto PhD, Associate Professor of Health Economics, Technical University of Lisbon, Lisbon, Portugal

1. To describe current methods used globally in health technology assessment and health care reimbursement policies
2. To assess adherence of current HTA methods to published HTA principles.
3. To describe important issues/trends reported by HTA bodies related to current research methods used in health technology assessment.

• Manuscript – submitted to Value in Health on May 9, 2010
  • Global Survey of Methods Used in Health Technology Assessment (HTA): Does Practice Meet the Principles Proposed for Good Research?
    
    
• Survey to assess current methods used globally in health technology assessment and health care reimbursement
  • Survey Results on Most Common Methodologies for Drugs by Stage